Oxford Immunotec Reports Fourth Quarter and Full Year 2015 Financial Results
Fourth quarter revenue of $16.8 million increased 42% on a constant currency basis compared to prior year period 2015 revenue of $62.8 million increased 33% on a constant currency basis compared to prior year T-SPOT®.PRT assay made available in the United …